Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Poststroke cognitive impairments and their therapy with ceraxon

https://doi.org/10.14412/2074-2711-2011-168

Full Text:

Abstract

Objective: to evaluate the effect of citicoline (ceraxon) on recovery of cognitive functions in patients after ischemic stroke. Subjects and methods. Thirty-three patients (13 males and 20 women) aged 46-82 years (mean age 66.5±6.75 years) after ischemic stroke were examined 3 months to 1 year after its development. Neuropsychological examination showed that all the patients had mild or moderate
cognitive impairments as disorders of memory, attention, and thinking. Results and discussion. Ten-day treatment with citicoline (ceraxon) in a dose of 500 or 1000 mg/day caused positive changes in the neurody-namic characteristics of cognitive functions, and improvements in memory, thinking, and health in the patients. Cognitive improvement was
more significant when ceraxon was used in a dose of 1000 mg/day.

References

1. <div><p>Бойко А.Н., Батышева Т.Т., Багирь Л.В. и др. Опыт амбулаторного применения препарата церепро при ишемическом инсульте в раннем восстановительном периоде. Журн невропат и психиатр 2007;107(10):34-40.</p><p>Дамулин И.В. Дифференциальная диагностика и терапия деменций. Consilium medicum 2003;5(12):721-6.</p><p>Парфенов В.А., Вахнина Н.В., Никитина Л.Ю. Лечение постинсультных когнитивных нарушений. РМЖ 2010;18:16.</p><p>Hershey L. Dementia associated with stroke. Stroke 1989;21(Suppl. 9):12-3.</p><p>Pasquier F., Leys D. Why are stroke patients prone to develop dementia? J Neurol 1997;244:135-42.</p><p>Patel M., Coshall C., Rudd A. et al. Natural history of cognitive impairmentafter stroke and factors associated with its recovery. Cerebrovasc Dis 2001;1(Suppl. 4):9.</p><p>Desmond D.W., Morony J.T., Raik M.C. et al. Freguency and clinical determinatts of dementia after scchemic stroke. Neurology 2000;54:1124-31.</p><p>Voisin T., de Feneyrols R.A., le Traon P.A. et al. Cognitive impairment after first lacunar stroke: clinical features and risk factors. Cerebrovasc Dis 2002;13(Suppl. 3):69.</p><p>Roman G.C. Facts, myths, and controversies in vascular dementia. J Neurol Sci 2004;226:49-52.</p><p>oeLb C., Gandolfo C., Croce R. et al. Dementia associated with lacunar infarction. Stroke 1992;23(9):1225-9.</p><p>Baron J.C., Levasseur M., Mazoyer B. et al. Thalamo-cortical diaschisis: positron emission tomography in humans. J Neurol Neurosurg Psychiat 1992;55:935-42.</p><p>Gustafson L., Passant U. Clinical pathological correlates. In: Cerebrovascular Disease, Cognitive Impairment and Dementia. J.O. Brien et al. (eds). London, New York: Martin Dunitz, 2004;197-210.</p><p>Reilly M., Connolly S., Stack J. et al. Bilateral paramedian thalamic infarction: adistict but poorly recognized stroke syndrome. Q J Med 1992;297:63-70.</p><p>Mielke R., Kessler J., Szelies B. et al. Vascular demencia: perfusional and metabolic disturbances and effects therapy. J Neurol Transm 1996;47(Suppl. 1):183-91.</p><p>Saver J.L. Цитиколин: новые сведения о перспективном лекарственном средстве, осуществляющем нейропротекцию и нейрорепарацию. Международн неврол журн 2010;1(31):108-17.</p><p>Афанасьев В.В. Клиническое применение цитиколина и его роль в гемостазе клеточных мембран нейронов и органов эффекторов. Трудн пациент 2009;7(11):26-32.</p><p>Андреева Г.Н., Рождественский А.С., Маркелова М.В. и др. Клиническая эффективность использования цераксона в острейшем периоде ишемического инсульта. Леч заб ЦНС 2010;2:29-31.</p><p>Tanaka Y., Minematsu K., Hirano T. et al. Effects of CDP-choline on dynamic changes in LCBF and cognitive function in demented sub-jecte-PET study. Rinsho Shinkeigaku 1994;34:877-81.</p><p>Левин О.С. Применение цитиколина в лечении инсульта. РМЖ 2008;26:1772-6.</p><p>Левин О.С., Дударова М.А., Усольцева Н.И. Диагностика и лечение постинсультных когнитивных нарушений. Consilium medicum 2010;12(2):5-12.</p><p>Скворцова В.И., Бойцова А. Нейропротективная терапия в остром периоде церебрального инсульта. Врач 2007;12:25-8.</p><p>Eberhardt R., Dehrr I. Eficacia y tolerancia de CDP-colina en pacientes geriatricos con insuficiencia cerebral senile. Rev Esp Geriatr Gerontol 1989;24(Suppl.1):73-81.</p><p>Fioravanti M., Buckley A.E., Agnoli A. Citicoline in CCVD patients: Preliminary results of a multicenter study. Cerebral Pathology in Old Age: Neuroradiological and Neurophysiological Correlation. Pavia, 1982</p></div><br />


For citation:


Shakhparonova N.V., Kadykov A.S., Kashina E. Poststroke cognitive impairments and their therapy with ceraxon. Neurology, Neuropsychiatry, Psychosomatics. 2011;3(3):56-60. (In Russ.) https://doi.org/10.14412/2074-2711-2011-168

Views: 397


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)